Pages

▼
Wednesday, September 28, 2022

Insilico Medicine CEO Alex Zhavoronkov featured among World’s Top 50 Innovators

›
     Insilico Medicine founder and CEO Alex Zhavoronkov, PhD will speak as part of the   World’s Top 50 Innovators , presented September 26-...
Wednesday, July 6, 2022

Deep Longevity granted the first microbiomic aging clock patent

›
The patent describes a technology to create anti-aging diets and probiotic treatments  The neural network that can estimate the age of a per...
Friday, April 1, 2022

Insilico identifies therapeutic targets implicated in aging using AI and hallmarks of aging framework

›
  Identifying dual-purpose therapeutic targets that are implicated in aging and disease will extend healthspan and delay age-related health ...
Wednesday, March 30, 2022

Ulta Beauty & Haut.AI partner to bring new era of beauty and healthcare with AI-powered hyper-personalization

›
  Ulta Beauty and Haut.AI partner to develop disruptive, inclusive, personalized artificial intelligence engine for skin health and beauty T...
Friday, March 25, 2022

Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform

›
  The Pharma.AI platform combining deep generative models (GAN), reinforcement learning (RL), transformers, and other modern machine learnin...
Thursday, March 10, 2022

Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis

›
 - Cystinosis is a rare genetic disease affecting 1 in 100,000-200,000 live births and poses a lifelong risk to those affected. Cystinosis s...
Tuesday, November 30, 2021

Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico's Proprietary End-to-end Artificial Intelligence Platform

›
NEW YORK and HONG KONG, Nov. 30, 2021 /PRNewswire/ -- Insilico Medicine , an end-to-end artificial intelligence (AI)-driven drug discovery c...